Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_provenance.
- NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_assertion description "[We analyzed the influence of angiotensin-converting enzyme (ACE) I/D, angiotensinogen (AGT) M235T and angiotensin-II-type-1 receptor (AT1R) A1166C genetic polymorphisms on the clinical course of focal segmental glomerulosclerosis (FSGS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_provenance.
- NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_assertion evidence source_evidence_literature NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_provenance.
- NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_assertion SIO_000772 14610337 NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_provenance.
- NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_assertion wasDerivedFrom befree-20140225 NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_provenance.
- NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_assertion wasGeneratedBy ECO_0000203 NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_provenance.
- befree-20140225 importedOn "2014-02-25" NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_provenance.